Turner Heather D Insider Trades

Insider Trading History

Track insider trading activity for Turner Heather D. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $0 0 shares
Last Trade
May 05, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.86M 110,697 shares
$52.97
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $89.9k 1,697 shares
Last Trade
Feb 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58.7k 1,697 shares
$34.60
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $2.38M 45,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$185k 45,000 shares
$4.10
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $3.39M 64,000 shares
Last Trade
Nov 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$365k 64,000 shares
$5.70
$52.95
Lyell Immunopharma
Lyell Immunopharma LYEL
Chief General Counsel
Holding Value $3.92M 300,000 shares
Last Trade
Mar 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.9M 300,000 shares
$119.60
$13.05
Lyell Immunopharma
Lyell Immunopharma LYEL
Chief General Counsel
Holding Value $0 0 shares
Last Trade
Jun 16, 2021 Sale
No data
No data
$13.05
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Evp, General Counsel & Sec.
Holding Value $24.2k 115,500 shares
Last Trade
Feb 25, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 134,750 shares
$9.03
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
SVP And General Counsel
Holding Value $41.9k 200,000 shares
Last Trade
Feb 28, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.79M 200,000 shares
$23.95
$0.21
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Former Evp, GC & Sec.
Holding Value $792k 77,112 shares
Last Trade
Feb 09, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$12.7M 12,214 shares
$1,042.50
$10.27
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Evp, General Counsel & Sec.
Holding Value $839k 81,708 shares
Last Trade
Feb 06, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.97M 4,434 shares
$895.00
$10.27
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Evp, General Counsel & Sec.
Holding Value $891k 86,775 shares
Last Trade
Feb 09, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.92M 12,215 shares
$402.50
$10.27
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Evp, General Counsel & Sec.
Holding Value $1.01M 98,357 shares
Last Trade
Feb 06, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.6M 49,500 shares
$376.25
$10.27
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Vp, General Counsel & Sec.
Holding Value $411k 40,000 shares
Last Trade
Sep 22, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.5M 40,000 shares
$511.50
$10.27
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Vp, General Counsel & Sec.
Holding Value $502k 48,857 shares
Last Trade
Feb 09, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.3M 48,857 shares
$394.50
$10.27
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Vp, General Counsel & Sec.
Holding Value $668k 65,000 shares
Last Trade
Dec 17, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.9M 65,000 shares
$568.00
$10.27
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Vp, General Counsel & Sec.
Holding Value $1.34M 130,000 shares
Last Trade
Aug 03, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$185M 130,000 shares
$1,424.50
$10.27

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up